Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
<p>Collaboration aims to validate Evotec's proprietary BiTco costimulatory CD2 bispecifics platform in combination with Plectonic's logic-gated DNA-protein immunotherapy technology LOGIBODY® BiTco designed to boost T cell activation by engaging a costimulatory signaling pathway LOGIBODY®...</p>
Read original article ↗
Related Articles
Alteogen signs deal with Novartis worth up to $3.2 bil. for subcutaneous formulations
Korean biotechnology company Alteogen Inc. said Wednesday that it signed an option and licensing agreement with Novartis
ASUS Showcases ProArt PCs Powered by NVIDIA RTX Spark at IFA 2026
ASUS unveils ProArt P16, P14 and GR1X mini PC on NVIDIA RTX Spark: up to 1 petaflop of AI and 128GB unified memory, show
EBook – Accelerate Silicon Design for Physical AI (Part 1)
A complete path from AI model, to trusted silicon, to deployable system. The post EBook – Accelerate Silicon Design for
Certified and integrated ecosystem within BC Mosaic helps healthcare and life sciences teams accelerate research and inn